217 related articles for article (PubMed ID: 35327653)
1. The Impact of NRF2 Inhibition on Drug-Induced Colon Cancer Cell Death and p53 Activity: A Pilot Study.
Garufi A; Pistritto G; D'Orazi V; Cirone M; D'Orazi G
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327653
[TBL] [Abstract][Full Text] [Related]
2. Nuclear factor erythroid 2 (NF-E2) p45-related factor 2 interferes with homeodomain-interacting protein kinase 2/p53 activity to impair solid tumors chemosensitivity.
D'Orazi G; Garufi A; Cirone M
IUBMB Life; 2020 Aug; 72(8):1634-1639. PubMed ID: 32593231
[TBL] [Abstract][Full Text] [Related]
3. A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status.
Garufi A; Baldari S; Pettinari R; Gilardini Montani MS; D'Orazi V; Pistritto G; Crispini A; Giorno E; Toietta G; Marchetti F; Cirone M; D'Orazi G
J Exp Clin Cancer Res; 2020 Jun; 39(1):122. PubMed ID: 32605658
[TBL] [Abstract][Full Text] [Related]
4. NRF2 activation in BON‑1 neuroendocrine cancer cells reduces the cytotoxic effects of a novel Ruthenium(II)‑curcumin compound: A pilot study.
Garufi A; Pettinari R; Monteonofrio L; Puliani G; Virdia I; Appetecchia M; Marchetti F; Cirone M; Soddu S; D'Orazi G
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186307
[TBL] [Abstract][Full Text] [Related]
5. Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2.
Tung MC; Lin PL; Wang YC; He TY; Lee MC; Yeh SD; Chen CY; Lee H
Oncotarget; 2015 Dec; 6(39):41692-705. PubMed ID: 26497680
[TBL] [Abstract][Full Text] [Related]
6. Spindle Assembly Checkpoint Inhibition Can Resensitize p53-Null Stem Cells to Cancer Chemotherapy.
Liu C; Banister CE; Buckhaults PJ
Cancer Res; 2019 May; 79(9):2392-2403. PubMed ID: 30862715
[TBL] [Abstract][Full Text] [Related]
7. Luteolin promotes apoptotic cell death via upregulation of Nrf2 expression by DNA demethylase and the interaction of Nrf2 with p53 in human colon cancer cells.
Kang KA; Piao MJ; Hyun YJ; Zhen AX; Cho SJ; Ahn MJ; Yi JM; Hyun JW
Exp Mol Med; 2019 Apr; 51(4):1-14. PubMed ID: 30988303
[TBL] [Abstract][Full Text] [Related]
8. Osthole promotes the suppressive effects of cisplatin on NRF2 expression to prevent drug-resistant cervical cancer progression.
Su J; Zhang F; Li X; Liu Z
Biochem Biophys Res Commun; 2019 Jun; 514(2):510-517. PubMed ID: 31056260
[TBL] [Abstract][Full Text] [Related]
9. Ergothioneine mitigates cisplatin-evoked nephrotoxicity via targeting Nrf2, NF-κB, and apoptotic signaling and inhibiting γ-glutamyl transpeptidase.
Salama SA; Abd-Allah GM; Mohamadin AM; Elshafey MM; Gad HS
Life Sci; 2021 Aug; 278():119572. PubMed ID: 33964294
[TBL] [Abstract][Full Text] [Related]
10. A functional pseudogene, NMRAL2P, is regulated by Nrf2 and serves as a coactivator of NQO1 in sulforaphane-treated colon cancer cells.
Johnson GS; Li J; Beaver LM; Dashwood WM; Sun D; Rajendran P; Williams DE; Ho E; Dashwood RH
Mol Nutr Food Res; 2017 Apr; 61(4):. PubMed ID: 27860235
[TBL] [Abstract][Full Text] [Related]
11. Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy.
Wang S; El-Deiry WS
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15095-100. PubMed ID: 14645705
[TBL] [Abstract][Full Text] [Related]
12. A Novel Polyphenol Conjugate Sensitizes Cisplatin-Resistant Head and Neck Cancer Cells to Cisplatin via Nrf2 Inhibition.
Kim EH; Jang H; Roh JL
Mol Cancer Ther; 2016 Nov; 15(11):2620-2629. PubMed ID: 27550943
[TBL] [Abstract][Full Text] [Related]
13. Curcumin induces p53-independent inactivation of Nrf2 during oxidative stress-induced apoptosis.
Méndez-García LA; Martínez-Castillo M; Villegas-Sepúlveda N; Orozco L; Córdova EJ
Hum Exp Toxicol; 2019 Aug; 38(8):951-961. PubMed ID: 31018701
[TBL] [Abstract][Full Text] [Related]
14. Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents.
Do MT; Kim HG; Choi JH; Jeong HG
Free Radic Biol Med; 2014 Sep; 74():21-34. PubMed ID: 24970682
[TBL] [Abstract][Full Text] [Related]
15. USP39 attenuates the antitumor activity of cisplatin on colon cancer cells dependent on p53.
Yuan J; Li X; Zhang Y; Zhang G; Cheng W; Wang W; Lei Y; Song G
Cell Biol Toxicol; 2023 Oct; 39(5):1995-2010. PubMed ID: 34822033
[TBL] [Abstract][Full Text] [Related]
16. Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism.
Cucci MA; Grattarola M; Dianzani C; Damia G; Ricci F; Roetto A; Trotta F; Barrera G; Pizzimenti S
Free Radic Biol Med; 2020 Apr; 150():125-135. PubMed ID: 32101771
[TBL] [Abstract][Full Text] [Related]
17. Synergy between sulforaphane and selenium in protection against oxidative damage in colonic CCD841 cells.
Wang Y; Dacosta C; Wang W; Zhou Z; Liu M; Bao Y
Nutr Res; 2015 Jul; 35(7):610-7. PubMed ID: 26094214
[TBL] [Abstract][Full Text] [Related]
18. Trolox contributes to Nrf2-mediated protection of human and murine primary alveolar type II cells from injury by cigarette smoke.
Messier EM; Bahmed K; Tuder RM; Chu HW; Bowler RP; Kosmider B
Cell Death Dis; 2013 Apr; 4(4):e573. PubMed ID: 23559007
[TBL] [Abstract][Full Text] [Related]
19. NRF2 and p53: Januses in cancer?
Rotblat B; Melino G; Knight RA
Oncotarget; 2012 Nov; 3(11):1272-83. PubMed ID: 23174755
[TBL] [Abstract][Full Text] [Related]
20. [Wogonoside reverses cisplatin resistance in SGC7901/cDDP cells through inhibition of PI3K/Akt/Nrf2/ARE signaling pathway].
Wang LJ; Wang SG; Deng TX
Sheng Li Xue Bao; 2018 Aug; 70(4):397-405. PubMed ID: 30112565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
